KBC Securities - KBC Securities Morning Note 25-1-2019 ABI BB, BAMNB NA, BPOST BB, EURN BB, HEIJM NA, IBAB BB, OBEL BB, QFG BB, SIP BB, SLIGR NA

Report

KBC Securities

KBC Securities Morning Note 25-1-2019 ABI BB, BAMNB NA, BPOST BB, EURN BB, HEIJM NA, IBAB BB, OBEL BB, QFG BB, SIP BB, SLIGR NA

AB InBev: $ 16.3bn bonds tendered in offer
BAM Group: Small investment in Irish modular homes
bpost: Changes to the executive committee
Euronav: 4Q18 Conf call feedback
Heijmans: Provisional AMC contract of â‚¬ 68.5m
IBA: IBA comments on Belgian KCE report
Orange Belgium: Take on promotional video Michael Trabbia
Quest for Growth: FY18 Results, NAV at â‚¬ 7.12 p.s., down 33.5% y/y
Sligro: Feedback Analyst Meeting

25/01/2019 13 EN

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Other Reports from KBC Securities

Guy Sips ... (+9)

Guy Sips
Hilde Van Boxstael
Kristof Samoy
Lynn Hautekeete
Thibault Leneeuw
Thomas Couvreur
Thomas Vranken
Wim Hoste
Wim Lewi

Morning Notes : ADYEN NA, ASML NA, BESI NA, FLOW NA, FUR NA, HEIA NA, HOMI BB, KIN BB, VGP BB, WDP BB, XFAB FP, AZE BB, ONWD BB

: ADYEN NA, ASML NA, BESI NA, FLOW NA, FUR NA, HEIA NA, HOMI BB, KIN BB, VGP BB, WDP BB, XFAB FP, AZE BB, ONWD BB

6h / 24m 6h / 24m 1 EN

Thomas Vranken

Thomas Vranken

Onward Medical FIRST LOOK: FY23 results as expected, 2024 outlook confirmed

Onward reported its FY23 results, and confirmed its FY24 outlook and key milestones. 2024 is set to become the year of its first launch, with ARCEX approval expected 2H24. Meanwhile, the pivotal trial in blood pressure control with ARCIM remains planned to start 2H24. YE23 cash landed at € 29.8m and was complemented with a € 20m equity raise to deliver cash runway into mid-2025. We reiterate our Buy rating and € 9.3 TP.

6h / 42m 6h / 42m 1 EN

Wim Hoste

Wim Hoste

Heineken Volume & pricing trends underpin resilient character

Heineken reported better than expected 1Q organic total volume trends (+4.3%). Even when stripping out easy comparatives in Nigeria & Vietnam, 1Q results show a combination of both underlying volume growth and further price/mix improvement which is in our opinion a testimony to the resilience of both Heineken and the broader beer category. FY24 guidance calling for a low to high single digit organic operating profit (beia) growth was maintained, but the CFO's comments in the conference call that he feels at ease with consensus (+7%) show that management clearly hopes to land in the upper half ...

6h / 43m 6h / 43m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

KBC Securities Morning Note 25-1-2019 ABI BB, BAMNB NA, BPOST BB, EURN BB, HEIJM NA, IBAB BB, OBEL BB, QFG BB, SIP BB, SLIGR NA

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : ADYEN NA, ASML NA, BESI NA, FLOW NA, FUR NA, HEIA NA, HOMI BB, KIN BB, VGP BB, WDP BB, XFAB FP, AZE BB, ONWD BB

Onward Medical FIRST LOOK: FY23 results as expected, 2024 outlook confirmed

Heineken Volume & pricing trends underpin resilient character

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe